Nonlytic Fc-fused IL-7 synergizes with Mtb32 DNA vaccine to enhance antigen-specific T cell responses in a therapeutic model of tuberculosis

Medicine and Dentistry

• DNA 100%
• Interleukin 7 100%
• T-Cell Response 50%
• DNA Vaccine 50%
• Chemotherapy 37%
• Tuberculosis 25%
• Mycobacterium Tuberculosis 25%
• Combination Therapy 12%
• Peptide 12%
• Immunogenicity 12%
• Spleen 12%
• Epitope 12%
• Cellular Immunity 12%
• Immunization 12%
• DNA Immunization 12%
• Antigen Specificity 12%
• Pneumonia 12%
• Dexamethasone 12%
• Pulmonary Pathology 12%
• Enzyme Linked Immunospot Assay 12%
• Flt3 Ligand 12%
• Intracellular Cytokine Staining 11%

Agricultural and Biological Sciences

• DNA 100%
• Interleukin 7 88%
• T Cell 44%
• Mycobacterium Tuberculosis 33%
• CD4 11%
• Peptide 11%
• Aerosol 11%
• Spleen 11%
• Dexamethasone 11%

Immunology and Microbiology

• Interleukin 7 88%
• T Cells 44%
• DNA Vaccine 44%
• Mycobacterium Tuberculosis 33%
• Mouse Model 11%
• CD8 11%
• Adoptive Immunity 11%
• Immunogenicity 11%
• CD4 11%
• Spleen 11%
• Antigen Specificity 11%
• Pulmonary Inflammation 11%
• Dexamethasone 11%
• Flt3 Ligand 11%